News, Analysis & Insights on Nutrition, Supplements, and Health
VitamINSIGHTS
Growth opportunities are plenty in Cambodia’s health supplements scene, due to a growing middle class and lower market competition, say Singapore’s Incontech and Australia’s Healthy Vitality which entered Cambodia in the last two years.
Here is a round-up on the latest nutraceutical trends in Asia-Pacific, including insights from Lonza on growing joint health interest among younger consumers, Haleon seeing China consumers increasing vitamin spendings in e-commerce, and popular demands...
Blackmores’ strong sales performance in Q3 FY2024 has helped parent company Kirin reduce the operating loss coming from its health science business.
The United States remains the number one market for probiotic supplementation, but double-digit growth in China could see the Asian country replace the U.S. in “a year, maybe two,” says the executive director of the International Probiotics Association...
China health supplements giant BYHEALTH continues to see weak performance as net profits fell 106.30 per cent in Q3 of 2024, resulting in a net loss of RMB$22.42m (US$3.15m). The company reported a net profit of RMB$355.7m (US$49.5m) during the same time...
OmniActive Health Technologies has acquired ENovate Biolife, expanding its ingredients portfolio to target key health categories in the dietary supplement space.
The food and beverage sector in Indonesia believes that it is high time for a larger scale food innovation centre focusing on the advancement and development of domestic companies to be established in the country.
Vitafoods Asia 2024
Dong-A Pharmaceutical is now looking to grow its exports markets, focusing on kids and beauty-from-within supplements in South East Asia, the company told us in Vitafoods Asia held in Bangkok.
Hong Kong consumers spend an average of HK$781.59 (US$100.53) on health supplements each month, say findings of a new survey commissioned by the Hong Kong Health Food Association (HKHFA).
Nestle is reintegrating the Greater China region with the rest of Asia, as new CEO Laurent Freixe unveiled a significant U-turn from its 2021 geographical ‘sharpening’ strategy.
Nutrachampion podcast
Thomas Sibel, co-founder of effervescent tablet vitamin brand VOOST sold to P&G in 2021, has set out to transform the supplements sector through his new venture Nordia Vitamins – a clean label vitamin brand focusing on powders.
The New Zealand government will introduce a new bill specifically to regulate natural products in the country, but no decisions have been taken on the scope or approach to be adopted, officials have announced.
China may allow health foods in the form of chocolates, candies, jellies, and beverages to go through the official health foods filing process.
NutraIngredients-Asia Awards 2024
The winner of NutraIngredients-Asia Awards 2024 Start-up of the Year says investing in research is key for start-ups to stand out from competition and it is aiming to do more in this area, with five clinical trials in the pipeline.
Vitafoods Asia 2024
AstaReal has launched an initiative to identify authentic astaxanthin supplements from counterfeits in Thailand, which is experiencing strong demand for astaxanthin products led by homegrown brand Dr. Pong.
Dubai-based healthy snack brand Linafsi is adopting several strategies to overcome stiff competition, including flavour innovation and localisation, exploring new product formats, and expanding sales channels.
Leading industry experts from Life-Space Group, Swisse Wellness, and the International Probiotics Association (IPA) and more will be presenting insights on the latest developments and research findings surrounding the microbiome sector in APAC in our...
Here is a round-up on the latest nutraceutical trends, including how probiotics are increasingly viewed as a valuable healthcare tool in South East Asia, strong demand for hair nutrition products among young women post-COVID, a look into China's liver...
NutraIngredients-Asia Awards 2024
There are market opportunities in Asia-Pacific’s sports nutrition sector specifically targeted at middle-aged adults, says the winner of this year’s NutraIngredients-Asia Awards Product of the Year Sports Nutrition.
Japan’s Daiichi Sankyo Healthcare Co Ltd has acquired sports nutrition brand DNS as it continues to grow its portfolio from pharmaceuticals to functional foods, oral and skin care.
The palm oil and other agrifood sectors may have breathed a collective sigh of relief at the European Commission (EC) announcement that EUDR enforcement will be delayed – but experts are warning that the root problems are yet to be resolved.
NutraIngredients-Asia Awards 2024
Ramasamy Venkatesh, managing director and founder of Gencor Pacific and the newly crowned Nutrachampion in this year’s NutraIngredients-Asia’s Awards, says that his company is developing nutraceutical ingredients for promoting the body’s GLP-1...
We look at the latest regulatory announcements happening across Asia-Pacific's health and nutrition sector, such as growing interest in acquiring halal-certification among food firms, and new regulatory initiatives by Food Standards Australia New Zealand...
Dame Health, a nutrition and wellness brand co-founded by an IVF doctor, is partnering fellow practitioners in driving the uptake of prenatal nutrition across India.
The world’s largest dairy importer has turned increasingly dairy self-sufficient. How is this impacting key commodity exports?
Australia-based Jatcorp will focus on building its nutrition brands and potentially acquire at least one new brand in the upcoming year, as it moves away from product distribution and OEM.
NutraIngredients-Asia Awards 2024
The winners of the NutraIngredients-Asia Awards 2024 have been announced in Bangkok, at a ceremony to celebrate the region’s brightest and best ingredients, products, research and initiatives.
China’s growing liver health supplement category is being driven by consumers seeking products for detoxification, skin brightening, and less so for anti-hangover.
Japan’s beverage giant Kirin has completed the acquisition of FANCL and is now aiming to “become one of the largest health science companies in Asia-Pacific.”
This round-up looks at how Asia-Pacific's health and nutrition companies have fared in their latest financial performance, featuring insights from Comvita, Bubs Australia, Feihe, EZZ Life Sciences, and H&H Group.
German food supplement company Orthomol is aiming to replicate its South Korea success in other markets, especially in Asia and the Middle East.
China energy drink heavyweight EastRoc is moving to a multi-beverage portfolio, hoping to establish itself as a leader in the wider beverage industry and not just the energy category.
China’s demand for coenzyme Q10 remains high but gross margin from the business is at the lower end, says Kingdomway, also the owner of health supplement brand Doctor’s Best.
Here is a round-up on the latest nutraceutical trends, including the rise of femcare products in Japan, how anti-ageing is driving nicotinamide mononucleotide (NMN) use in Hong Kong, and growing demand for red ginseng in China and Vietnam.
Manuka honey maker Comvita says annual revenue for FY24 is down by 12.7 per cent, citing economic slowdown in its largest market, China, as the main reason for the “disappointing” performance.
Bubs Australia, known for its goat milk formula, says its annual revenue has returned to growth on the back of efforts to diversify its business outside of China.
Formula giant Feihe’s half-year profit for FY24 is up 18.1 per cent on the back of increased marketing activities which is said to have acquired over 1.4 million new customers.
Australian firm EZZ Life Science Holdings Limited says net profit for FY24 is up 91 per cent, led by strong e-commerce demand for two of its products in China – nicotinamide mononucleotide (NMN) and a bone health supplement.
Health and Happiness Group (H&H Group) saw its net profit plummeted 49.7 per cent for the first six months of this year – a “challenging period” which it said was primarily due to a downturn and discounting in the infant milk formulas segment.
Qatari dairy firm Baladna has announced plans to double down on its new product innovation and international market expansion strategy, particularly in Algeria, after seeing a record growth in net profits over the first six months of 2024.
Nutrachampion podcast
Life-Space’s former CEO and founder Craig Silbery is making a return to the human biotics space as he seeks to make Australia a world-class site for manufacturing probiotics and postbiotics, he told our Nutrachampion podcast.
The recent ban on nicotinamide mononucleotide (NMN) into China via cross-border e-commerce was due to safety considerations, says a local industry association, which added that several China companies have put forth their products for health foods...
VitamINSIGHTS
Nicotinamide mononucleotide (NMN) has become one of the hottest health supplement categories in Hong Kong, on the back of strong demand for anti-ageing products, say Catalo, NUNMN, and Homart in this edition of our in-depth VitamINSIGHTS analysis.
South Korea’s domestic demand for red ginseng has slowed down in the past year, but the sector is seeing opportunities overseas, especially in neighbouring East Asian countries and Vietnam.
Japanese adults in their 20s and 30s are most interested in personalised nutrition as compared to the other age groups, a survey conducted by Suntory-backed start-up Rem3dy Health has found.
Kava is seeing a rapid uptake in Australia as consumers are looking to replace alcohol with a healthier alternative, says kava firm The Calmer Co.
China Nutrition and Health Food Association (CNHFA) has drafted a set of industry standards to measure nicotinamide mononucleotide (NMN) amounts in health supplements.
Our Healthy Beverages APAC editorial webinar is going live and coming your way on August 21 – register your attendance today so you don’t miss out!
China’s hyaluronic acid manufacturer Bloomage says there is vast potential for South East Asia-manufactured nutraceuticals in the China market.
Kirin plans to acquire another overseas asset or pour more investment into Blackmores if the deal to acquire FANCL does not go as planned.